Is Buying APHRIA INC ORDINARY SHARES CANADA (OTCMKTS:APHQF), Having Lower Short Interest a Winning Strategy?

October 2, 2018 - By Marguerite Chambers

The stock of APHRIA INC ORDINARY SHARES CANADA (OTCMKTS:APHQF) registered a decrease of 44.11% in short interest. APHQF’s total short interest was 5.75 million shares in October as published by FINRA. Its down 44.11% from 10.29 million shares, reported previously. With 5.33M shares average volume, it will take short sellers 1 days to cover their APHQF’s short positions.

The stock decreased 6.52% or $0.9026 during the last trading session, reaching $12.9474. About 787,874 shares traded. Aphria Inc. (OTCMKTS:APHQF) has 0.00% since October 2, 2017 and is . It has underperformed by 15.62% the S&P500.

Aphria Inc. produces, supplies, and sells medical cannabis in Canada. The company has market cap of $3.20 billion. The firm offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It has a 95.91 P/E ratio. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.

More notable recent Aphria Inc. (OTCMKTS:APHQF) news were published by: which released: “A Warning On Canadian Pot Stocks” on September 11, 2018, also with their article: “3 Canadian Marijuana Stocks With Reasonable Valuations” published on September 06, 2018, published: “Aphria: The Best Value Of The ‘Big 5’ Cannabis Producers” on September 24, 2018. More interesting news about Aphria Inc. (OTCMKTS:APHQF) were released by: and their article: “7 Up-and-Coming Stocks to Buy for the Fourth Quarter” published on September 28, 2018 as well as‘s news article titled: “Aurora Cannabis: This One Is ‘Just Right'” with publication date: September 18, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News